Health

Early findings on immune escape and transmissibility, combined with danger posed by Delta, heighten urgency of vaccination, testing, other safety measures.

As governments and health officials navigate pandemic, researchers stress the danger that comes with bad information.

An observational study finds that antibody levels are higher when health care workers received the SARS-CoV-2 vaccine in the afternoon.

A new study led by Harvard researchers models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.

With Omicron landing in the U.S. this week, Harvard epidemiologist William Hanage reviewed what we know and the many things still unknown about the fast-moving coronavirus variant.

Breakthrough COVID-19 cases in vaccinated people may be less likely to spread infection because virus is shed for a shorter period of time as opposed to infections in unvaccinated people.

In a comparison study, the Moderna vaccine was slightly more effective than the Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death.

Simar Singh Bajaj ’24 has had papers published in prestigious journals such as The New England Journal of Medicine and The Lancet.

Sarah Wakeman says that CDC report highlights need for U.S. to radically rethink response to opioid epidemic.

Mary Bushman, a research fellow in the Department of Epidemiology at Harvard Chan School, co-authored a recent paper that modeled variant threats.

A Harvard expert shares insight on the science and history of vaccine boosters and why we need them, speculating on a future that includes periodic COVID boosters.

Study says that physical activity later in life shifts energy away from processes that compromise health and toward mechanisms in the body that extend it.

Long COVID’s laundry list of ills include skepticism and doubt often conveyed in the doctors’ office.

New research points to a well-known and widely available drug called disulfiram (marketed as Antabuse) as a possible treatment for COVID-19.

A second untreated person living with HIV shows no evidence of intact HIV genomes, indicating that her immune system may have eliminated the HIV reservoir.

Researchers have developed an artificial intelligence-based method to predict the risk of atrial fibrillation within the next five years based on results from electrocardiograms.

With a new level of accuracy, research has shown that a decrease in sodium and an increase in potassium may lower the risk of cardiovascular disease.

The Chan School’s David Canning wants to follow the cognitive performance of chess players over time.

Harvard specialists say COVID-19 pills may cut hospitalizations and deaths and offer big boost to nations struggling with low vaccination rates.

Mass. General study uncovers potential new treatment strategy for disease.

One hundred years after the discovery of insulin, replacement therapy represents “a new kind of medicine,” says Douglas Melton, co-director of Harvard Stem Cell Institute.

Baby teeth may reveal clues about the effects of childhood adversity, which research suggests is responsible for up to one-third of all mental health disorders.

A human Intestine Chip has helped identify drugs that can target GI symptoms associated with both the common cold and SARS-CoV-2 virus infections.

A new decision-support tool helped preserve the health care workforce by distinguishing symptoms associated with COVID-19 vaccinations from symptoms of the virus itself.

Pediatric infectious disease specialist Kristin Moffitt offers parents insight on recently approved COVID-19 vaccines for children ages 5 to 11.

Researchers have identified a subset of neurons that must be present for acupuncture to trigger an anti-inflammatory response.

Love, death, fear, guilt, pride, hope, friendship, alienation, and so much sorrow. Through it all, they kept showing up.

With help from Kierkegaard, Rilke, and Heidegger, Susanna Siegel, Edgar Pierce Professor of Philosophy, examines the ways we process mortality.

Scientists find that a rapid rollout of the COVID vaccine to low- and middle-income countries is as important as the vaccine’s efficacy.

Wrestling with a health care conundrum: how to get people to listen?